We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00564161
Recruitment Status : Withdrawn
First Posted : November 27, 2007
Last Update Posted : September 2, 2016
Sponsor:
Information provided by:
Hadassah Medical Organization

Brief Summary:
We hypothesize that misexpression of vascular endothelial growth factor (VEGF) in the Cerebrospinal fluid of preterm infants can be used as a biomarker to predict the risk for developing white matter damage.

Condition or disease
Preterm Infants With White Matter Damage Preterm Infants Developing Normally

Study Type : Observational
Actual Enrollment : 0 participants
Time Perspective: Prospective
Official Title: VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants
Study Start Date : January 2008
Estimated Study Completion Date : January 2009

Group/Cohort
1
2



Biospecimen Retention:   Samples Without DNA
CSF.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   25 Weeks to 40 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
preterm infants.
Criteria

Inclusion Criteria:

  • Preterm infants undergoing lumbar puncture.

Exclusion Criteria:

  • Preterm with IVH or known infection or meningitis.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564161


Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Talya Dor, MD Hadassah Medical Organization

ClinicalTrials.gov Identifier: NCT00564161     History of Changes
Other Study ID Numbers: 606060-HMO-CTIL
First Posted: November 27, 2007    Key Record Dates
Last Update Posted: September 2, 2016
Last Verified: November 2007

Additional relevant MeSH terms:
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications